Navigation Links
Fetal Exposure to Epilepsy Drug Might Raise Autism Risk: Study
Date:12/5/2011

By Jenifer Goodwin
HealthDay Reporter

MONDAY, Dec. 5 (HealthDay News) -- Children exposed to the epilepsy drug valproate have a nearly three times higher risk of having an autism spectrum disorder, new research finds.

Researchers in Denmark used national birth data that included nearly 656,000 children born in that country between 1996 and 2006 to 428,000 women. Using a national prescription drug registry, they identified women who had filled a prescription for valproate (Depakote) shortly before pregnancy through the day of the child's birth.

Using the Danish Psychiatric Register, researchers then identified children who were diagnosed with an autism spectrum disorder, which can include both severe and milder forms of autism, and children with early-onset, more severe autism.

After taking into account certain factors such as maternal age, the child's gender and other factors that influence autism risk, researchers found that children exposed in utero to valproate were 2.6 times more likely to have an autism spectrum disorder and almost five times more likely to have early-onset autism.

The results were similar whether women were taking valproate alone or valproate along with other epilepsy drugs, leading researchers to conclude the dangers to fetal development were posed by the valproate and not another drug.

"We know from previous studies valproic acid is associated with an increased risk of congenital malformations, and in recent years some animal and human studies have suggested maybe there are neuropsychological effects, like autism," said study author Dr. Jakob Christensen, a consultant neurologist at Aarhus University Hospital in Aarhus, Denmark. "Our study adds more evidence of that."

However, he added, "even though we found an increased risk, it's still a very small risk."

Of their sample of almost 656,000 kids, the researchers said they found 508 who were likely exposed to valproic acid before birth. Of those, 14 developed autism.

Among the rest of the sample, about 0.8 percent of kids not exposed to the epilepsy drug developed autism. That would mean that if you took a group of 508 kids not exposed to the drug, about five of those would be diagnosed with the disorder, Christensen said.

The research is slated to be presented Monday at the American Epilepsy Society meeting in Baltimore.

Prior research has also raised concerns about valproic acid during pregnancy, leading the U.S. Food and Drug Administration and the American Academy of Neurology to issue warnings to women of childbearing age about valproate and other drugs in its class. A recent study in the Journal of the American Medical Association found that the offspring of women who took valproic acid during pregnancy are two to 12 times more likely to have serious births defects affecting the brain, heart and limbs.

And in a second study to be presented at the same meeting, researchers from the United States and the United Kingdom report that fetal exposure to valproic acid is associated with lower IQs at age 3 years.

For women with epilepsy of childbearing age, the increasing body of evidence that valproic acid may be dangerous to the fetus may present them with a difficult decision to make, said study author Dr. Kimford Meador, a professor of neurology at Emory University in Atlanta.

"You take all the research together, and it doesn't look like a very good drug for childbearing age," Meador said, noting that many pregnancies are unplanned.

However, for some women, valproic acid controls seizures when other medications have failed; for them, stopping the mediation when they're pregnant may not be an option, he said.

"About 15 percent of women do not respond to other drugs available, but they do respond to valproate," Meador said. "That's the difficulty -- it's not a simple yes-no thing."

Because this research was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on epilepsy.

SOURCES: Jakob Christensen, M.D., Ph.D, consultant neurologist, Aarhus University Hospital, Aarhus, Denmark; Kimford Meador, M.D, professor, neurology, Emory University, Atlanta; Dec. 5, 2011, presentation, American Epilepsy Society annual meeting, Baltimore


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fetal stem cells from placenta may help maternal heart recover from injury
2. Links to Mental Illness Seen in Fetal Brains: Study
3. Fetal Exposure to Magnetic Fields From Appliances, Power Lines May Up Kids Asthma Risk
4. NICHD renews maternal-fetal medicine, neonatal ties with Women & Infants
5. Fetal Exposure to Common Epilepsy Drugs May Harm Kids IQ: FDA
6. Fetal electrocardiogram helps in early detection of neonatal acidosis
7. Fetal programming of disease risk to next generation depends on parental gender
8. The TET1 enzyme steers us through fetal development and fights cancer
9. Society for Maternal-Fetal Medicine commends FDA on makena announcement
10. Study finds that electronic fetal heart rate monitoring greatly reduces infant mortality
11. Study finds even with fetal lung maturity, babies delivered prior to 39 weeks are at risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fetal Exposure to Epilepsy Drug Might Raise Autism Risk: Study 
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... of $3,296 in property taxes a year. In some states—like New York, New ... , By contrast, many overseas retirement havens have extremely low property-tax rates, which ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
Breaking Medicine Technology: